317 related articles for article (PubMed ID: 31529722)
21. An ANGPTL4-ceramide-protein kinase Cζ axis mediates chronic glucocorticoid exposure-induced hepatic steatosis and hypertriglyceridemia in mice.
Chen TC; Lee RA; Tsai SL; Kanamaluru D; Gray NE; Yiv N; Cheang RT; Tan JH; Lee JY; Fitch MD; Hellerstein MK; Wang JC
J Biol Chem; 2019 Jun; 294(23):9213-9224. PubMed ID: 31053639
[TBL] [Abstract][Full Text] [Related]
22. 5,5-Dimethyl-3-(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenyl-3-(trifluoromethyl)-3,5,6,7-tetrahydro-1H-indole-2,4-dione, a potent inhibitor for mammalian elongase of long-chain fatty acids family 6: examination of its potential utility as a pharmacological tool.
Shimamura K; Kitazawa H; Miyamoto Y; Kanesaka M; Nagumo A; Yoshimoto R; Aragane K; Morita N; Ohe T; Takahashi T; Nagase T; Sato N; Tokita S
J Pharmacol Exp Ther; 2009 Jul; 330(1):249-56. PubMed ID: 19359527
[TBL] [Abstract][Full Text] [Related]
23. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
[TBL] [Abstract][Full Text] [Related]
25. Ceramide Synthase 5 Is Essential to Maintain C16:0-Ceramide Pools and Contributes to the Development of Diet-induced Obesity.
Gosejacob D; Jäger PS; Vom Dorp K; Frejno M; Carstensen AC; Köhnke M; Degen J; Dörmann P; Hoch M
J Biol Chem; 2016 Mar; 291(13):6989-7003. PubMed ID: 26853464
[TBL] [Abstract][Full Text] [Related]
26. Dietary supplementation with myo-inositol reduces high-fructose diet-induced hepatic ChREBP binding and acetylation of histones H3 and H4 on the Elovl6 gene in rats.
Hibi M; Nakagawa T; Hayakawa T; Yanase E; Shimada M
Nutr Res; 2021 Apr; 88():28-33. PubMed ID: 33743322
[TBL] [Abstract][Full Text] [Related]
27. CerS1-Derived C
Turpin-Nolan SM; Hammerschmidt P; Chen W; Jais A; Timper K; Awazawa M; Brodesser S; Brüning JC
Cell Rep; 2019 Jan; 26(1):1-10.e7. PubMed ID: 30605666
[TBL] [Abstract][Full Text] [Related]
28. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
29. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
[TBL] [Abstract][Full Text] [Related]
30. Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.
Martínez L; Torres S; Baulies A; Alarcón-Vila C; Elena M; Fabriàs G; Casas J; Caballeria J; Fernandez-Checa JC; García-Ruiz C
Oncotarget; 2015 Dec; 6(39):41479-96. PubMed ID: 26539645
[TBL] [Abstract][Full Text] [Related]
31. Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation.
Sajan MP; Ivey RA; Lee MC; Farese RV
J Lipid Res; 2015 Jan; 56(1):70-80. PubMed ID: 25395359
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide.
Long Z; Cao M; Su S; Wu G; Meng F; Wu H; Liu J; Yu W; Atabai K; Wang X
Free Radic Biol Med; 2017 Dec; 113():71-83. PubMed ID: 28942246
[TBL] [Abstract][Full Text] [Related]
33. Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk.
Liu Y; Dou X; Zhou WY; Ding M; Liu L; Du RQ; Guo L; Qian SW; Tang Y; Yang QQ; Pan DN; Li XY; Lu Y; Cheng JK; Tang QQ
Hepatology; 2021 Oct; 74(4):1864-1883. PubMed ID: 33934381
[TBL] [Abstract][Full Text] [Related]
34. Ceramide synthase 6 mediates sex-specific metabolic response to dietary folic acid in mice.
Barron K; Ogretmen B; Krupenko N
J Nutr Biochem; 2021 Dec; 98():108832. PubMed ID: 34358645
[TBL] [Abstract][Full Text] [Related]
35. CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance.
Raichur S; Wang ST; Chan PW; Li Y; Ching J; Chaurasia B; Dogra S; Öhman MK; Takeda K; Sugii S; Pewzner-Jung Y; Futerman AH; Summers SA
Cell Metab; 2014 Oct; 20(4):687-95. PubMed ID: 25295789
[TBL] [Abstract][Full Text] [Related]
36. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
Liu X; Chen S; Zhang L
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
[TBL] [Abstract][Full Text] [Related]
37. ELOVL6 deficiency aggravates allergic airway inflammation through the ceramide-S1P pathway in mice.
Yoshida K; Morishima Y; Ano S; Sakurai H; Kuramoto K; Tsunoda Y; Yazaki K; Nakajima M; Sherpa MT; Matsuyama M; Kiwamoto T; Matsuno Y; Ishii Y; Hayashi A; Matsuzaka T; Shimano H; Hizawa N
J Allergy Clin Immunol; 2023 Apr; 151(4):1067-1080.e9. PubMed ID: 36592705
[TBL] [Abstract][Full Text] [Related]
38. Elovl6 Deficiency Improves Glycemic Control in Diabetic
Zhao H; Matsuzaka T; Nakano Y; Motomura K; Tang N; Yokoo T; Okajima Y; Han SI; Takeuchi Y; Aita Y; Iwasaki H; Yatoh S; Suzuki H; Sekiya M; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H
Diabetes; 2017 Jul; 66(7):1833-1846. PubMed ID: 28461456
[TBL] [Abstract][Full Text] [Related]
39. Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance.
Yew Tan C; Virtue S; Murfitt S; Roberts LD; Phua YH; Dale M; Griffin JL; Tinahones F; Scherer PE; Vidal-Puig A
Sci Rep; 2015 Dec; 5():18366. PubMed ID: 26679101
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis.
Yamada K; Mizukoshi E; Sunagozaka H; Arai K; Yamashita T; Takeshita Y; Misu H; Takamura T; Kitamura S; Zen Y; Nakanuma Y; Honda M; Kaneko S
Liver Int; 2015 Feb; 35(2):582-90. PubMed ID: 25219574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]